ATE234100T1 - Medikamente zur topischen anwendung von sexualhormonen zur behandlung des trockenen auges,und verfahren zu ihrer herstellung und anwendung - Google Patents
Medikamente zur topischen anwendung von sexualhormonen zur behandlung des trockenen auges,und verfahren zu ihrer herstellung und anwendungInfo
- Publication number
- ATE234100T1 ATE234100T1 AT91917537T AT91917537T ATE234100T1 AT E234100 T1 ATE234100 T1 AT E234100T1 AT 91917537 T AT91917537 T AT 91917537T AT 91917537 T AT91917537 T AT 91917537T AT E234100 T1 ATE234100 T1 AT E234100T1
- Authority
- AT
- Austria
- Prior art keywords
- dry eye
- medications
- treatment
- production
- topical application
- Prior art date
Links
- 208000003556 Dry Eye Syndromes Diseases 0.000 title abstract 3
- 206010013774 Dry eye Diseases 0.000 title abstract 3
- 229940079593 drug Drugs 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 230000000699 topical effect Effects 0.000 title abstract 2
- 229940088597 hormone Drugs 0.000 title 1
- 239000005556 hormone Substances 0.000 title 1
- 230000001568 sexual effect Effects 0.000 title 1
- 239000003981 vehicle Substances 0.000 abstract 2
- HRGSZQQJTWZVHP-ZBRFXRBCSA-N Estra-1,3,5(10)-triene-3,17beta-diol 3-phosphate Chemical compound OP(=O)(O)OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 HRGSZQQJTWZVHP-ZBRFXRBCSA-N 0.000 abstract 1
- 208000009319 Keratoconjunctivitis Sicca Diseases 0.000 abstract 1
- 239000008135 aqueous vehicle Substances 0.000 abstract 1
- 229940035811 conjugated estrogen Drugs 0.000 abstract 1
- QTTMOCOWZLSYSV-QWAPEVOJSA-M equilin sodium sulfate Chemical compound [Na+].[O-]S(=O)(=O)OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4C3=CCC2=C1 QTTMOCOWZLSYSV-QWAPEVOJSA-M 0.000 abstract 1
- 239000000262 estrogen Substances 0.000 abstract 1
- 229940011871 estrogen Drugs 0.000 abstract 1
- 239000003163 gonadal steroid hormone Substances 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 150000003431 steroids Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US1991/005863 WO1993003731A1 (en) | 1991-08-17 | 1991-08-17 | Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE234100T1 true ATE234100T1 (de) | 2003-03-15 |
Family
ID=22225745
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT91917537T ATE234100T1 (de) | 1991-08-17 | 1991-08-17 | Medikamente zur topischen anwendung von sexualhormonen zur behandlung des trockenen auges,und verfahren zu ihrer herstellung und anwendung |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5041434A (de) |
| EP (1) | EP0652754B1 (de) |
| AT (1) | ATE234100T1 (de) |
| DE (2) | DE69133214T2 (de) |
| DK (1) | DK0652754T3 (de) |
| ES (1) | ES2086268T3 (de) |
| GR (1) | GR960300027T1 (de) |
| WO (1) | WO1993003731A1 (de) |
Families Citing this family (92)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5041434A (en) * | 1991-08-17 | 1991-08-20 | Virginia Lubkin | Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application |
| DE4038128A1 (de) * | 1990-11-27 | 1992-06-04 | Schering Ag | 8-en-19, 11(beta)-ueberbrueckte steroide, deren herstellung und diese enthaltende pharmazeutische praeparate |
| US5958912A (en) * | 1992-04-21 | 1999-09-28 | The Schepens Eye Research Institute, Inc. | Ocular therapy in keratoconjunctivitis sicca using topically applied androgens of TGF-β |
| US5352445A (en) * | 1992-05-07 | 1994-10-04 | Lavaux Joseph E | Lavaux tear test lacrimal equilibration time (LET) |
| US5827245A (en) * | 1992-07-16 | 1998-10-27 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg | Transdermal therapeutic system comprising the active subtance 17-β-Estradiol (Anhydrous) |
| US5290572A (en) * | 1992-08-06 | 1994-03-01 | Deo Corporation | Opthalmic composition for treating dry eye |
| US5830508A (en) * | 1992-08-06 | 1998-11-03 | Deo Corporation | Composition for treating dry eye |
| WO1994004155A1 (en) * | 1992-08-19 | 1994-03-03 | Health Resource Institute, Ltd. | Dehydroepiandrosterone therapy for the treatment of eye disorders |
| US5639743A (en) * | 1992-11-13 | 1997-06-17 | University Of Georgia Research Foundation | Compositions and methods for treating exocrine gland atrophy |
| US5696166A (en) * | 1995-10-31 | 1997-12-09 | Yanni; John M. | Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders |
| WO1997020578A1 (en) * | 1995-12-04 | 1997-06-12 | University Of Miami | Non-preserved topical corticosteroid for treatment of dry eye, filamentary keratitis, and delayed tear clearance |
| AUPO427196A0 (en) * | 1996-12-19 | 1997-01-23 | University Of Sydney, The | A method for preventing or controlling cataract |
| ZA989513B (en) | 1997-10-21 | 1999-04-21 | Alcon Lab Inc | Compositions containing histamine H2 agonists and methods of use in treating dry eye |
| US6096733A (en) * | 1998-12-10 | 2000-08-01 | Virginia Lubkin | Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application |
| AU2183900A (en) | 1998-12-24 | 2000-07-31 | Alcon Laboratories, Inc. | Ep4 receptor agonists for treatment of dry eye |
| US6803385B2 (en) | 1999-11-09 | 2004-10-12 | Alcon, Inc. | Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders |
| WO2001034553A2 (en) | 1999-11-09 | 2001-05-17 | Alcon Universal Ltd. | 2,2-difluoro 15-hydroxyeicosatetraenoic acid analogs and methods of use |
| US6458854B2 (en) | 1999-11-09 | 2002-10-01 | Alcon Universal Ltd. | Phospholipids of hydroxyeicosatetraenoic acid-like derivatives and methods of use |
| US6353032B1 (en) | 1999-11-09 | 2002-03-05 | Alcon Universal Ltd. | Phospholipids of hydroxyeicosatetraenoic acid-like derivatives and methods of use |
| WO2001034550A2 (en) | 1999-11-09 | 2001-05-17 | Alcon Universal Ltd. | 15-hydroxyeicosatetraenoic acid analogs with enhanced metabolic stability and methods of their use in treating dry eye disorders |
| EP1227809B1 (de) | 1999-11-09 | 2005-04-06 | Alcon Inc. | Heteroatomunterbrochene analoge von15-hydroxyeicosatetraensäure und verfahren zu deren verwendung |
| MXPA02004700A (es) | 1999-11-09 | 2004-09-10 | Alcon Inc | Compuestos relacionados con acido 15-hidroxieicosatetraenoico y metodos de uso. |
| US6552084B2 (en) | 1999-11-09 | 2003-04-22 | Alcon Universal Ltd. | Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders |
| ES2220561T3 (es) | 1999-11-09 | 2004-12-16 | Alcon Inc. | Composiciones que contienen derivados de acido hidroxieicosa tetraenoico y metodo de uso para tratar trastornos de la xeroftalmia. |
| BR0015436A (pt) | 1999-11-09 | 2002-07-16 | Alcon Inc | Sais de hidroxieicosatetraenoato, composições e métodos de uso no tratamento de distúrbios dos olhos secos |
| ES2208440T3 (es) | 1999-11-09 | 2004-06-16 | Alcon Inc. | Derivados del acido 15-hidroxieicosatetraenoico con cadena omega modificada utiles para el tratamiento del ojo seco. |
| PT1228030E (pt) | 1999-11-09 | 2005-08-31 | Alcon Inc | Derivados benzenoidicos do acido 15-hidroxieicosatetraenoico e metodos para a sua utilizacao no tratamento das perturbacoes do olho seco |
| ATE258791T1 (de) | 1999-11-09 | 2004-02-15 | Alcon Inc | Lipoxin-a4 und deren analoge zur behandlung von trockenen augen |
| DK1228027T3 (da) | 1999-11-09 | 2004-07-19 | Alcon Inc | 3-heteroatomsubstituerede og to carbonhomologe af 15-HETE og fremgangsmåder til anvendelse |
| WO2001046134A1 (en) | 1999-12-22 | 2001-06-28 | Alcon Universal Ltd. | 6-KETO PROSTAGLANDIN F1α AND ANALOGS FOR TREATING DRY EYE |
| AUPR549901A0 (en) | 2001-06-06 | 2001-07-12 | Vital Health Sciences Pty Ltd | Topical formulation containing tocopheryl phosphates |
| US20040097472A1 (en) * | 2000-11-14 | 2004-05-20 | West Simon Michael | Complexes of phosphate derivatives |
| US6872382B1 (en) | 2001-05-21 | 2005-03-29 | Alcon, Inc. | Use of selective PDE IV inhibitors to treat dry eye disorders |
| US7112588B2 (en) * | 2001-05-21 | 2006-09-26 | Alcon, Inc. | Use of proteasome inhibitors to treat dry eye disorders |
| DK1393277T3 (da) | 2001-05-21 | 2006-10-30 | Alcon Inc | Anvendelse af NF-Kappa-B inhibitorer til behandling af öjentörhedslidelser |
| BR0209882A (pt) * | 2001-05-21 | 2004-06-08 | Alcon Inc | Método para o tratamento de distúrbios de olho seco |
| ES2278049T3 (es) | 2001-05-21 | 2007-08-01 | Alcon, Inc. | Uso de inhibidores de proteasoma para tratar trastornos de ojo seco. |
| US6645994B1 (en) | 2001-06-01 | 2003-11-11 | Alcon, Inc. | Method of treating dry eye disorders |
| US6750250B1 (en) * | 2001-07-12 | 2004-06-15 | Alcon, Inc. | 11,12-oxidoarachidonic acid derivatives and methods of their use in treating dry eye disorders |
| MXPA04000654A (es) * | 2001-07-27 | 2004-03-19 | Vital Health Sciences Pty Ltd | Terapia dermica usando derivados de fosfato de agente de transferencia de electrones. |
| US20030175329A1 (en) * | 2001-10-04 | 2003-09-18 | Cellegy Pharmaceuticals, Inc. | Semisolid topical hormonal compositions and methods for treatment |
| WO2003030892A1 (en) * | 2001-10-11 | 2003-04-17 | Alcon, Inc. | Methods for treating dry eye |
| CA2462272A1 (en) * | 2001-10-11 | 2003-04-17 | Alcon, Inc. | Methods for treating dry eye by a combination of an antiinflammatory steroid and a muc-1 secretagogue |
| WO2003030894A1 (en) * | 2001-10-11 | 2003-04-17 | Alcon, Inc. | Methods for treating dry eye |
| WO2003049774A1 (en) * | 2001-12-13 | 2003-06-19 | Vital Health Sciences Pty Ltd | Transdermal transport of compounds |
| US6659985B2 (en) | 2002-01-30 | 2003-12-09 | Southern College Of Optometry | Method to use transdermal administration of androgens to the adnexa of the eye |
| US20070213310A1 (en) * | 2002-04-01 | 2007-09-13 | Laszlo Prokai | Prodrugs for Use as Ophthalmic Agents |
| US7186707B2 (en) * | 2002-04-01 | 2007-03-06 | University Of Florida | Prodrugs for use as ophthalmic agents |
| AU2002950713A0 (en) * | 2002-08-09 | 2002-09-12 | Vital Health Sciences Pty Ltd | Carrier |
| JP2006502183A (ja) * | 2002-09-20 | 2006-01-19 | アルコン,インコーポレイテッド | ドライアイ障害の処置のためのサイトカイン合成インヒビターの使用 |
| WO2004045510A2 (en) * | 2002-11-15 | 2004-06-03 | Panaseca, Inc. | Methods and compositions for alleviating dry eyes |
| WO2004069248A1 (en) * | 2002-12-09 | 2004-08-19 | University Of Florida | Prodrugs for use a ophthalmic agents |
| WO2004060274A2 (en) * | 2002-12-20 | 2004-07-22 | Alcon, Inc. | Treatment of dry eye by restoring 15-lipoxygenase activity to ocular surface cells |
| JP4690305B2 (ja) * | 2003-01-17 | 2011-06-01 | バイタル ヘルス サイエンシズ プロプライアタリー リミティド | 抗増殖性質を有する化合物 |
| AU2003901815A0 (en) * | 2003-04-15 | 2003-05-01 | Vital Health Sciences Pty Ltd | Phosphate derivatives |
| US7235556B2 (en) * | 2003-04-16 | 2007-06-26 | Alcon, Inc. | Methods of treating dry eye disorders |
| RU2477136C2 (ru) * | 2004-03-03 | 2013-03-10 | Вайтал Хэлф Сайнсис Пти Лтд | Алкалоидные составы |
| DK1755616T3 (da) | 2004-04-08 | 2013-11-25 | Eye Co Pty Ltd | Behandling af ekssudativ retinopati med mineralkortikoider |
| US7923471B2 (en) * | 2004-05-14 | 2011-04-12 | Alcon, Inc. | Method of treating dry eye disorders and uveitis |
| PL1744736T3 (pl) * | 2004-05-14 | 2010-03-31 | Alcon Inc | Sposób leczenia zespołu suchego oka i zapalenia błony naczyniowej oka |
| US7223737B1 (en) | 2004-08-13 | 2007-05-29 | Alcon, Inc. | Method of treating dry eye disorders using glycosides |
| WO2006065916A1 (en) * | 2004-12-14 | 2006-06-22 | Alcon, Inc. | Method of treating dry eye disorders using 13(s)-hode and its analogs |
| US9161905B2 (en) * | 2005-01-12 | 2015-10-20 | Ocular Research Of Boston, Inc. | Dry eye treatment |
| AU2006218655A1 (en) * | 2005-03-02 | 2006-09-08 | Nascent Pharmaceutical. Inc. | Combinaion therapy for topical application in the treatment of dry eye syndrome |
| JP2008531602A (ja) * | 2005-03-03 | 2008-08-14 | バイタル ヘルス サイエンシズ プロプライアタリー リミティド | 抗癌特性を有する化合物 |
| KR101254938B1 (ko) | 2005-06-10 | 2013-04-16 | 포라가세이고오교오가부시끼가이샤 | 신규 트리테르펜산 유도체 및 이를 포함하는 피부 외용제 |
| US9168216B2 (en) * | 2005-06-17 | 2015-10-27 | Vital Health Sciences Pty. Ltd. | Carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof |
| US20090005348A1 (en) * | 2005-12-23 | 2009-01-01 | Vital Health Sciences Pty Ltd | Compounds Having Cytokine Modulating Properties |
| US7745461B1 (en) | 2006-02-27 | 2010-06-29 | Alcon Research, Ltd. | Method of treating dry eye disorders |
| DK2374472T3 (en) | 2006-03-16 | 2018-08-13 | Dyax Corp | Compositions and Methods for the Treatment of Eye Disorders |
| US20080132475A1 (en) * | 2006-12-05 | 2008-06-05 | Charles Gerald Connor | Treatment for dry eye |
| WO2008109780A1 (en) * | 2007-03-06 | 2008-09-12 | University Of Louisville Research Foundation, Inc | Methods and compounds for the targeted delivery of agents to bone for interaction therewith |
| KR101472609B1 (ko) | 2007-04-02 | 2014-12-15 | 디에스엠 아이피 어셋츠 비.브이. | 제니스테인의 신규 용도 |
| WO2009007839A1 (en) * | 2007-07-11 | 2009-01-15 | Pfizer Inc. | Pharmaceutical compositions and methods of treating dry eye disorders |
| WO2009052140A1 (en) * | 2007-10-15 | 2009-04-23 | Alcon Research, Ltd. | Use of tnf receptor antagonists for treating dry eye |
| TW200927192A (en) * | 2007-11-19 | 2009-07-01 | Alcon Res Ltd | Use of TRPV1 receptor antagonists for treating dry eye and ocular pain |
| US20100016264A1 (en) * | 2007-12-05 | 2010-01-21 | Connor Charles G | Treatment for dry eye using testosterone and progestagen |
| US8207226B1 (en) | 2008-06-03 | 2012-06-26 | Alcon Research, Ltd. | Use of FAAH antagonists for treating dry eye and ocular pain |
| EP2396324A1 (de) | 2009-02-13 | 2011-12-21 | Fovea Pharmaceuticals | [1,2,4]triazolo[1,5-a]pyridine als kinaseinhibitoren |
| AU2010314956A1 (en) * | 2009-11-06 | 2012-04-12 | Alcon Research, Ltd. | Nutritional supplements for relief of dry eye |
| WO2011094814A1 (en) | 2010-02-05 | 2011-08-11 | Phosphagenics Limited | Carrier comprising non-neutralised tocopheryl phosphate |
| CA2794734C (en) | 2010-03-30 | 2017-12-12 | Phosphagenics Limited | Transdermal delivery patch |
| TW201204723A (en) | 2010-06-22 | 2012-02-01 | Fovea Pharmaceuticals | Heterocyclic compounds, their preparation and their therapeutic application |
| US20120079612A1 (en) * | 2010-09-24 | 2012-03-29 | West Virginia University | Dry eye animal model |
| WO2012122586A1 (en) | 2011-03-15 | 2012-09-20 | Phosphagenics Limited | New composition |
| US10004714B2 (en) * | 2012-07-09 | 2018-06-26 | Brien Holden Vision Institute | Compositions, methods and/or devices for prevention and/or treatment of dry eye disorders |
| US10507245B2 (en) * | 2012-07-19 | 2019-12-17 | Luis Felipe Vejarano Restrepo | Ophthalmic formulation and method for ameliorating presbyopia |
| WO2015009787A1 (en) * | 2013-07-19 | 2015-01-22 | The Johns Hopkins University | Biomaterials comprising hyaluronic acid binding peptides and extracellular matrix binding peptides for hyaluronic acid retention and tissue engineering applications |
| US10973761B2 (en) | 2015-12-09 | 2021-04-13 | Phosphagenics Limited | Pharmaceutical formulation |
| JP7583515B2 (ja) | 2016-06-20 | 2024-11-14 | ノバルティス アーゲー | TNFα拮抗薬を使用したドライアイ疾患の治療方法 |
| JP7198754B2 (ja) | 2016-12-21 | 2023-01-04 | アベーチョ バイオテクノロジー リミテッド | 方法 |
| US10843325B2 (en) | 2017-03-08 | 2020-11-24 | DePuy Synthes Products, Inc. | Quick coupling apparatus on instrument handle |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2861920A (en) * | 1954-05-04 | 1958-11-25 | Upjohn Co | Therapeutic suspensions of steroids containing pvp and/or pva |
| US3299104A (en) * | 1963-04-09 | 1967-01-17 | Leo Ab | Certain steroid nu-bis-(haloethyl)-carbamates |
| US3962430A (en) * | 1974-08-07 | 1976-06-08 | Merck & Co., Inc. | Sterilization of solid non-electrolyte medicinal agents employing sodium chloride |
| US4154820A (en) * | 1976-02-23 | 1979-05-15 | Akzona Incorporated | Compositions containing alkali metal sulfate salts of conjugated estrogens and antioxidants as stabilizers |
| US4082881A (en) * | 1976-12-23 | 1978-04-04 | E. R. Squibb & Sons, Inc. | Topical and other type pharmaceutical formulations containing isosorbide carrier |
| HU181703B (en) * | 1980-05-09 | 1983-11-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing aqueus solutuins of water insoluble or hardly soluble vitamines, steroides, localanesthetics, prostanoides and non-steroid and antiphlogistic agents |
| JPS58126810A (ja) * | 1981-12-24 | 1983-07-28 | Kaken Pharmaceut Co Ltd | 抗炎症眼科用液剤およびその製法 |
| US4478818A (en) * | 1982-12-27 | 1984-10-23 | Alza Corporation | Ocular preparation housing steroid in two different therapeutic forms |
| US4581226A (en) * | 1983-04-07 | 1986-04-08 | Dillon Richard S | Method of treating sensitive animal tissue with a specially processed seawater solution |
| US4474751A (en) * | 1983-05-16 | 1984-10-02 | Merck & Co., Inc. | Ophthalmic drug delivery system utilizing thermosetting gels |
| SE8305864D0 (sv) * | 1983-10-25 | 1983-10-25 | L E Medical | Ogondroppar |
| US4617299A (en) * | 1983-12-19 | 1986-10-14 | Knepper Paul A | Method for the prevention of ocular hypertension, treatment of glaucoma and treatment of ocular hypertension |
| US4812448A (en) * | 1984-10-22 | 1989-03-14 | Knepper Paul A | Method for the prevention of ocular hypertension, treatment of glaucoma and treatment of ocular hypertension |
| US4863912A (en) * | 1986-05-19 | 1989-09-05 | New York Medical College | Use of tetrahydrocortisol in glaucoma therapy |
| US4774236A (en) * | 1986-09-17 | 1988-09-27 | Research Triangle Institute | 17α-(substituted-methyl)-17β-hydroxy/esterified hydroxy steroids and pharmaceutical compositions containing them |
| US4861763A (en) * | 1986-09-17 | 1989-08-29 | Research Triangle Institute | 17 α-(substituted-methyl)-17β-hydroxy/esterified hydroxy steroids and their progestational use |
| US4866049A (en) * | 1987-08-10 | 1989-09-12 | Spectra Pharmaceutical Services, Inc. | Ophthalmic compositionn and method of using same |
| US4954490A (en) * | 1988-06-23 | 1990-09-04 | Research Triangle Institute | 11 β-substituted progesterone analogs |
| US4951683A (en) * | 1989-01-19 | 1990-08-28 | Davis Jeffrey P | Device for detecting keratoconjunctivitis sicca |
| US5041434A (en) * | 1991-08-17 | 1991-08-20 | Virginia Lubkin | Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application |
-
1990
- 1990-05-07 US US07/520,077 patent/US5041434A/en not_active Ceased
-
1991
- 1991-08-17 DK DK91917537T patent/DK0652754T3/da active
- 1991-08-17 EP EP91917537A patent/EP0652754B1/de not_active Expired - Lifetime
- 1991-08-17 AT AT91917537T patent/ATE234100T1/de not_active IP Right Cessation
- 1991-08-17 DE DE69133214T patent/DE69133214T2/de not_active Expired - Fee Related
- 1991-08-17 WO PCT/US1991/005863 patent/WO1993003731A1/en not_active Ceased
- 1991-08-17 DE DE0652754T patent/DE652754T1/de active Pending
- 1991-08-17 ES ES91917537T patent/ES2086268T3/es not_active Expired - Lifetime
-
1996
- 1996-05-31 GR GR960300027T patent/GR960300027T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0652754B1 (de) | 2003-03-12 |
| ES2086268T1 (es) | 1996-07-01 |
| WO1993003731A1 (en) | 1993-03-04 |
| DE69133214T2 (de) | 2003-12-18 |
| DE652754T1 (de) | 1996-09-12 |
| DE69133214D1 (de) | 2003-04-17 |
| GR960300027T1 (en) | 1996-05-31 |
| US5041434A (en) | 1991-08-20 |
| EP0652754A4 (de) | 1994-11-09 |
| EP0652754A1 (de) | 1995-05-17 |
| ES2086268T3 (es) | 2003-11-16 |
| DK0652754T3 (da) | 2003-06-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69133214D1 (de) | Medikamente zur topischen anwendung von sexualhormonen zur behandlung des trockenen auges, und verfahren zu ihrer herstellung und anwendung | |
| KR870010862A (ko) | 비내투여용 수성 스테로이드 제제 | |
| ATE214931T1 (de) | Antibakterielle präparate für die ohren ohne irritierende, sensibilisierende und ototoxische wirkungen | |
| ATE175353T1 (de) | Verfahren und system zur empfängnisverhütung | |
| ATE215814T1 (de) | Galenische einzeldosierung zur lokalen hormontherapie der vaginalen trockenheit | |
| GR900100481A (el) | Μέ?οδος παρακευής υδατικού αιωρήματος για ουσιαστικά αδιάλυτους στο νερό ενεργούς παράγοντες. | |
| HUP9801234A2 (hu) | Nitroglicerint tartalmazó, vizes alapú, helyileg alkalmazható krém, eljárás előállítására és alkalmazása | |
| NO307445B1 (no) | Farmasøytiske preparater inneholdende nanokapsler og fremgangsmõte for fremstilling derav | |
| ES2130622T3 (es) | Sistema para la administracion transdermica de farmacos. | |
| SE9503143D0 (sv) | New preparation | |
| ATE198152T1 (de) | Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe | |
| CA2419404A1 (en) | Compositions and methods for treating sexual dysfunction | |
| BR9709934A (pt) | Kit de terapia de reposição hormonal e/ou contraceptivo uso de unidades de dosagem diária consistindo essecialmente de um progestogênio e processo de preparação de um sistema de liberação de droga | |
| KR920703041A (ko) | 통증을 수반하는 염증성 또는 알레르기성 질환치료에 사용되는 성분물과 그 방법 | |
| CA2392050A1 (en) | Pharmaceutical formulations containing zolmitriptan | |
| DE69602412D1 (de) | Ophthalmische Zubereitung zur Behandlung oder Prävention von trockenem Auge und Krankheiten, die dadurch verursacht werden, enthaltend 12-Sulfodehydroabietsäure | |
| TR200002078T2 (tr) | Sentetik polisakkaridler, hazırlanmaları için proses ve bunları içeren farmasötik kompozisyonlar. | |
| ATE172117T1 (de) | Verwendung von trospiumchlorid zur herstellung eines arzneimittels zur behandlung von blasenkrankheiten | |
| KR950016760A (ko) | 치질 치료제 | |
| EP0711169A4 (de) | Androstansteroide als neurochemische initiatoren einer veränderung der hypothalamusfunktion beim menschen und verwandte pharmazeutische präparate und verfahren | |
| KR930019224A (ko) | 유산 위험 치료제 | |
| EP0715517A4 (de) | Estrensteroide als neurochemische initiatoren einer veränderung der hypothalmusfunktion beim menschen und verwandte pharmazeutische präparate und verfahren | |
| ES2084348T3 (es) | N-((4,5-dihidroxi- y 4,5,8-trihidroxi-9,10-dihidro-9,10-dioxo-2-antracen-il)carbonil)aminoacidos utiles en la terapia de afecciones osteoarticulares. | |
| KR920703060A (ko) | 제약학적 배합물 | |
| ES2060440T3 (es) | Derivados de acidos 1,4-dihidropiridin-dicarboxilicos aril-quinolil substituidos, procedimiento para su fabricacion y su uso en medicamentos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0652754 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |